Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 01.02.2024
J P Jenkins Ltd
01st February 2024
JPJ: TNT
Tintra Limited
Shares now trading at JP Jenkins
1st February 2024 – Shares in Tintra Limited (https://tintra.com/) have been admitted to trade on JP Jenkins share dealing platform. Tintra Limited is based at 2nd Floor, Berkley Square House, Berkley Square, London, W1J 6BD and is registered as a company in [ … ]
Thu, 01.02.2024
Eurobattery Minerals AB
EQS-Media / 01.02.2024 / 13:05 CET/CEST
The Board of Directors of Eurobattery Minerals AB (Nordic Growth Market: BAT and Börse Stuttgart: EBM; in short: “Eurobattery” or the “Company”) has today, with support from the authorisation from the Extraordinary General Meeting on 27 December 2023, decided on a directed issue of 4,980,152 units to und [ … ]
Thu, 01.02.2024
JPMorgan ETFs (Ireland) ICAV
COMPANY ANNOUNCEMENT
For Immediate Release
01 February 2024
JPMorgan ETFs (Ireland) ICAV
RE: Dividends
The Directors of JPMorgan ETFs (Ireland) ICAV (the "Company") wish to announce the following dividends which are ex dividend as of the 08 February 2024, record date as of the 09 Fe [ … ]
Thu, 01.02.2024
Your Family Entertainment AG
Corporate News of Your Family Entertainment AG
"Innovation through partnerships:
Your Family Entertainment AG integrates artificial intelligence (AI) into its corporate strategy"
Munich, February 1, 2024
Your Family Entertainment AG (YFE), a leading listed media company in family entertainment (WKN: A161N1, ISIN: DE000A161N14, abbreviation: [ … ]
Thu, 01.02.2024
Immunic, Inc.
Immunic to Participate in Investor and Scientific Conferences in February
NEW YORK, February 1, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and sc [ … ]
Thu, 01.02.2024
Linde plc
Linde Signs Long-Term Agreements to Purchase Renewable Energy in China
Woking, UK, February 1, 2024 – Linde (Nasdaq: LIN) announced today it has signed two new long-term power purchase agreements for the supply of renewable energy in China.
Linde has signed separate 25-year agreements with Guangdong Energy Group (GEG) and China Three Gorges Corpo [ … ]
Thu, 01.02.2024
Medios AG
Press Release
Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
Berlin, February 1, 2024 – The Supervisory Board of Medios AG ("Medios") has decided to extend the existing Executive Board contracts of Mi-Young Miehler (Chief Operating Officer / COO) and Christoph Prußeit (Chi [ … ]
Thu, 01.02.2024
Photon Energy NV
Powering Progress: Photon Energy Commissions its 10th PV Power Plant in Romania
Located in Bocșa, Caraș-Severin County, the 3.8 MWp installation expands the Photon Energy’s Romanian IPP (Independent Power Producer) portfolio to 39.1 MWp.
In the coming weeks, the Company is set to commission an additional three power plants in Romania with a c [ … ]
Thu, 01.02.2024
adesso SE
adesso kicks off new year with major orders / Two long-term contracts with well-known enterprises
adesso has concluded a new framework agreement spanning multiple years with a leading mobility provider. The order covers the provision of IT consulting and services and has a maximum volume running into middle double-digit millions of euros figure. T [ … ]
Thu, 01.02.2024
Nordea Bank Abp
Nordea Bank Abp
/ Key word(s): Transaction in Own Shares
Transaction in Own Shares
01.02.2024 / 08:45 CET/CEST
Nordea Bank Abp: Repurchase of own shares on 31.01.2024
Nordea Bank Abp
Stock exchange release - Changes in company's own shares
31.01.2024 at 22.30 EET
Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 31.0 [ … ]